Dr. Hilderson Ingeborg Oncologe: what changed
What changed
Dr. Hilderson Ingeborg Oncologe
filed annual accounts (NBB)
Net result for the year
€81,657
2024 · €25,941+€55,716
Equity
€107,765
2024 · €26,941+€80,824
Cash
€27,751
2024 · €35,376-€7,625
Balance sheet total
€112,615
2024 · €36,127+€76,488
Largest movements
Assets
- Current investments +€75,000
new in 2025: €75,000
- Cash -€7,625
down €7,625 (-21.6%), from €35,376 to €27,751
mainly Current investments (-€75,000) and Tax, wage and social debts (-€5,171)
- Deferred charges and accrued income +€5,084
up €5,084 (+5,188%), from €98 to €5,182
- Tangible fixed assets +€4,146
new in 2025: €4,146
Equity and liabilities
- Reserves +€80,824
up €80,824 (+312%), from €25,941 to €106,765
- Tax, wage and social debts -€5,171
down €5,171 (-58.8%), from €8,799 to €3,628
of which Taxes: -€5,161
Income statement
- Gross operating margin +€71,018
up €71,018 (+215%), from €33,059 to €104,077
- Taxes +€14,940
up €14,940 (+227%), from €6,573 to €21,514
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€25,941
Gross operating margin
+€71,018
Depreciation
-€489
Other operating charges
-€147
Financial income
+€365
Financial charges
-€91
Taxes
-€14,940
Result 2025
€81,657
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€72,843
Investment
-€79,634
Financing
-€833
Cash 2024
€35,376
From operations (derived)
+€72,843
Net result for the year
+€81,657
Depreciation
+€489
Smaller working-capital items
+€120
Deferred charges and accrued income
-€5,084
Tax, wage and social debts
-€5,171
Other debts
+€833
Investment (derived)
-€79,634
Investment in fixed assets (net)
-€4,634
Current investments
-€75,000
Financing
-€833
Contributions, distributions and other
-€833
Cash 2025
€27,751
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,127 | €112,615 | +€76,488 | +212% |
| Fixed assets | 21/28 | - | €4,146 | +€4,146 | |
| Tangible fixed assets | 22/27 | - | €4,146 | +€4,146 | |
| Furniture and vehicles | 24 | - | €4,146 | +€4,146 | |
| Current assets | 29/58 | €36,127 | €108,470 | +€72,342 | +200% |
| Amounts receivable within one year | 40/41 | €654 | €536 | -€117 | -17.9% |
| Trade receivables | 40 | €497 | €0 | -€497 | -100% |
| Other amounts receivable | 41 | €156 | €536 | +€380 | +243% |
| Current investments | 50/53 | - | €75,000 | +€75,000 | |
| Cash at bank and in hand | 54/58 | €35,376 | €27,751 | -€7,625 | -21.6% |
| Deferred charges and accrued income | 490/1 | €98 | €5,182 | +€5,084 | +5,188% |
| Total equity and liabilities | 10/49 | €36,127 | €112,615 | +€76,488 | +212% |
| Equity | 10/15 | €26,941 | €107,765 | +€80,824 | +300% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €25,941 | €106,765 | +€80,824 | +312% |
| Distributable reserves | 133 | €25,941 | €106,765 | +€80,824 | +312% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €9,186 | €4,851 | -€4,336 | -47.2% |
| Amounts payable within one year | 42/48 | €9,186 | €4,851 | -€4,336 | -47.2% |
| Trade debts | 44 | €387 | €390 | +€3 | +0.7% |
| Suppliers | 440/4 | €387 | €390 | +€3 | +0.7% |
| Taxes, remuneration and social security | 45 | €8,799 | €3,628 | -€5,171 | -58.8% |
| Taxes | 450/3 | €6,573 | €1,412 | -€5,161 | -78.5% |
| Remuneration and social security | 454/9 | €2,226 | €2,216 | -€10 | -0.5% |
| Other amounts payable | 47/48 | - | €833 | +€833 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €489 | +€489 | |
| Other operating charges | 640/8 | €537 | €684 | +€147 | +27.4% |
| Gross operating margin | 9900 | €33,059 | €104,077 | +€71,018 | +215% |
| Operating profit (loss) | 9901 | €32,522 | €102,904 | +€70,382 | +216% |
| Financial income | 75/76B | - | €365 | +€365 | |
| Recurring financial income | 75 | - | €365 | +€365 | |
| Financial charges | 65/66B | €8 | €98 | +€91 | +1,208% |
| Recurring financial charges | 65 | €8 | €98 | +€91 | +1,208% |
| Profit (loss) for the period before taxes | 9903 | €32,514 | €103,171 | +€70,656 | +217% |
| Income taxes | 67/77 | €6,573 | €21,514 | +€14,940 | +227% |
| Profit (loss) for the period | 9904 | €25,941 | €81,657 | +€55,716 | +215% |
| Profit (loss) for the period to be appropriated | 9905 | €25,941 | €81,657 | +€55,716 | +215% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.